- Barrons.com•14 hours ago
Everyone who is everyone wants to buy Medivation (MDVN). Sanofi (SNY) has bid more than $9 billion for the biotech company, while Medivation is often presented as a cure for what ails Gilead Sciences (GILD). Pfizer (PFE), and Amgen (AMGN) have also been mentioned as potential suitors.
- Zacks•3 days ago
Celgene Corporation (CELG), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.38% last quarter.
After hours: 42.06-0.37 (-0.86%) as of 5:16 PM EDT
|Bid||42.26 x 100|
|Ask||42.50 x 200|
|52wk Range||37.41 - 54.98|
|Day's Range||41.96 - 42.46|
|Avg Vol (3m)||2,334,114|
As of 4:02 PM EDT. Market closed.